Stock Market & Financial News

Loading...
CVS Health: The Surprising Healthcare Outlier

CVS Health: The Surprising Healthcare Outlier

CVS Health Corporation has outperformed peers, overcoming industry headwinds through effective management and strategic execution. CVS delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low-double-digit investor returns. While Health Services and Insurance segments anticipate mid-single-digit growth, retail is set for gradual decline but with margin improvements.

CVS Health Corporation logo CVS
Seekingalpha | 2 weeks ago

2 Chip Stocks Driving Today's Rally With Lofty Bull Notes

Lam Research Corp (NASDAQ:LRCX) and Applied Materials Inc (NASDAQ:AMAT) are contributing to the semiconductor and memory stock rally this morning, after Goldman Sachs hiked its price targets on both names to $380 and $645, respectively.

Lam Research Corporation logo LRCX
Schaeffersresearch | 2 weeks ago

TeraWulf Stock Soars 17% on 20-Year Anthropic Lease Agreement

TeraWulf stock rises sharply after the data-center operator announces a 20-year lease agreement with AI start-up Anthropic.

TeraWulf Inc. logo WULF
Barrons | 2 weeks ago

Ethereum 'Reinventing Itself' With Biggest Overhaul Since the Merge: Vitalik Buterin

Nearly every core piece of the protocol will be rebuilt over three to four years, with quantum safety and privacy moved front and center.

ETHUSD
Decrypt | 2 weeks ago
How Nvidia Became The Black Sheep Of The Chip Stock Rally

How Nvidia Became The Black Sheep Of The Chip Stock Rally

NVIDIA's fundamentals have never looked stronger, yet its stock is limping through 2026.

NVIDIA Corporation logo NVDA
247wallst | 2 weeks ago
Strategy sells Bitcoin for the first time since 2022 to fund dividend payments

Strategy sells Bitcoin for the first time since 2022 to fund dividend payments

Strategy's Bitcoin sale highlights the potential vulnerability of relying on volatile assets for dividend funding, impacting investor confidence. Strategy sells Bitcoin for the first time since 2022 to fund dividend payments.

BTCUSD
Cryptobriefing | 2 weeks ago
Chipotle Mexican Grill: Burritos Don't Make The Difference, Operational Excellence Does

Chipotle Mexican Grill: Burritos Don't Make The Difference, Operational Excellence Does

Chipotle Mexican Grill is executing its 'Recipe for Growth' strategy, centered on five pillars that differentiate the brand and drive long-term expansion. Operational excellence is CMG's core competitive moat, supporting strong performance in a highly competitive fast-casual dining sector. CMG reported impressive Q1 2026 restaurant-level operating margins of 23.7%, demonstrating resilience despite inflationary pressures.

Cmg Holdings Group Inc. logo CMGO
Seekingalpha | 2 weeks ago
3 Natural Gas Stocks Built for America's Energy Power Shift

3 Natural Gas Stocks Built for America's Energy Power Shift

LNG, AR and GPOR offer three angles on rising natural gas demand as electricity use, grid reliability needs and LNG exports reshape U.S. energy.

Shift Technologies, Inc. logo SFT
Zacks | 2 weeks ago
Bitcoin ETFs Post First Negative Half With $5.4 Billion in Outflows, DWF Labs Says

Bitcoin ETFs Post First Negative Half With $5.4 Billion in Outflows, DWF Labs Says

Spot bitcoin ETFs recorded $5.4 billion in net outflows in the first half of 2026, marking their first negative half-year since launch. DWF Labs says the reversal reflects weaker crypto sentiment as capital and attention shift toward AI. DWF Labs Says AI Boom Coincides With Bitcoin ETFs' First $5.

BTCUSD
News | 2 weeks ago

AtaiBeckley completes dosing in Phase 2b depression trial, expects topline data in Q4

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) said on Monday that it has completed dosing the final patient in its Phase 2b Elumina clinical trial evaluating investigational therapy VLS-01 for adults with treatment-resistant depression (TRD), with topline results expected in the fourth quarter of 2026. The randomized, double-blind, placebo-controlled trial enrolled 156 patients across multiple centers.

AtaiBeckley Inc. logo ATAI
Proactiveinvestors | 2 weeks ago

Renault making higher profits on compact electric models than Megane, says CEO

Renault Group is achieving better margins on its compact electric R5 than ​larger models like the Megane or Scenic, ‌CEO Francois Provost told French business daily Les Echos on Monday.

Renault S.A. logo RNLSY
Reuters | 2 weeks ago

Explaining Wall Street's Tech Rotation, Memory Movers & META's AI Stance

Rotation is the theme of markets right now, says Tom White, pointing to selling in AI chip stocks while other corners of Wall Street rallied. Memory stocks remain in focus, as Tom points to movers like Micron (MU) in the U.S. and SK Hynix abroad with plans to make a domestic debut.

Meta Platforms Inc Class A logo META
Youtube | 2 weeks ago

Gold –06.07.2026

Gold managed to meet the target of 4200 early today. As we see from the chart, prices are facing a trading zone between support 4100 and resistance 4200-20.

XAUU
XAUUSD
Orbex | 2 weeks ago

USD/JPY –06.07.2026

USDJPY managed to pass above the short-term resistance zone of 161.95 which shows a strong advance still ongoing. Prices fell toward 160.50-70 on the suspected intervention before bouncing back.

USDJPY
Orbex | 2 weeks ago

GBP/USD –06.07.2026

GBPUSD rebounded further after testing the support at 1.3160 as the market closed from the 1.3400-30 resistance zone. If prices remain below this zone, another retreat toward 1.3305 and 1.3160 could hit the market.

GBPUSD
Orbex | 2 weeks ago

EUR/USD –06.07.2026

The Euro advanced after the US payroll last Friday. Intraday shows the same levels with support at 1.1380 could keep the chance for a move to test the 1.1500-25 resistance zone.

EURUSD
Orbex | 2 weeks ago

Oversold vs Undervalued: 3 Stocks Sitting in the Sweet Spot for Retirement Investors

What's the difference between a stock that is oversold and one that is undervalued?

Comcast Corp logo CMCSA
247wallst | 2 weeks ago

MBX Biosciences: Weekly PTH, Monthly Obesity, Multi-Year Upside (Initiating Buy)

I initiate MBX Biosciences with a speculative buy, anchored by Canvuparatide's de-risked clinical profile and differentiated dosing convenience. MBXX's Precision Endocrine Peptide platform enables longer-acting, less frequent dosing, addressing key safety and compliance issues in hypoparathyroidism and obesity. Canvuparatide's Phase 2 data show strong efficacy and patient benefit, but Phase 3 must address PK variability and long-term calcium control risks.

MBX Biosciences, Inc. logo MBX
Seekingalpha | 2 weeks ago

Mastercard: The Moat Justifies The Markup

Mastercard underperformed the benchmark, remaining flat over the past 7 months while the benchmark gained 9%. Despite recent underperformance, MA's long-term investment thesis has improved due to several emerging tailwinds. My previous neutral stance was justified, but evolving factors now support a more constructive outlook on MA.

Mastercard Incorporated logo MA
Seekingalpha | 2 weeks ago

Solstice Advanced Materials to Buy Element Solutions for More Than $12 Billion

Solstice Advanced Materials has struck a deal to buy specialty chemicals maker Element Solutions for more than $12 billion in cash and stock.

Element Solutions Inc. logo ESI
Wsj | 2 weeks ago

Solana active users surge 77% to 29.7M in two weeks

Solana's user surge highlights its growing influence and potential to boost market confidence, impacting blockchain competition dynamics. Solana active users surge 77% to 29.7M in two weeks.

SOLUSD
Cryptobriefing | 2 weeks ago

Cardano Price Prediction: Can Leios Upgrade Help ADA Challenge XRP After 4% Drop?

Cardano (ADA) slipped 4% on July 6, trading around $0.18 and emerging as the weakest performer among the top 10 cryptocurrencies by market capitalization. The decline comes as long liquidations and falling open interest increase selling pressure, even as Cardano founder Charles Hoskinson remains optimistic about the networks long-term outlook.

ADAUSD
Tokenpost | 2 weeks ago

GBP/USD: Dollar Slips on Weak Jobs, Sterling's Winning Streak Likely to Continue

The sterling pound has seen a notable recovery in recent weeks, following a sharp decline in late June. The GBP/USD pair has experienced a seven-session winning streak, moving from a seven-month low near $1.3200 to the $1.3350-$1.3380 range.

GBPUSD
Investingcube | 2 weeks ago

Bitcoin Pulls Back After Touching $64K, Momentum Fizzles Quickly

Bitcoin touched $64,000 for the first time in roughly two weeks but quickly lost more than $1,000 and moved back below $63,000. June delivered a 20% decline, Bitcoin's worst month in exactly four years, before July's dip under $58,000 and subsequent rebound.

BTCUSD
Crypto-economy | 2 weeks ago

Rocket Lab stock analysis: megaphone forms as experts remain optimistic

Rocket Lab stock has remained volatile in the wake of the highly anticipated SpaceX IPO and its blockbuster Iridium acquisition. Shares surged to $151 ahead of the IPO before tumbling to $80.50, and have since recovered to around $100.

Rocket Lab Corporation logo RKLB
Invezz | 2 weeks ago

Rogers Communications Buys Remaining MLSE Stake from Kilmer Sports for About $3.06 Billion

Rogers Communications is buying out the final portion of the Maple Leaf Sports and Entertainment from Larry Tanenbaum's Kilmer Sports for 4.35 billion Canadian dollars.

Rogers Corporation logo ROG
Wsj | 2 weeks ago

XRP Price Prediction: Traders See Potential Rally to $1.30 as Bullish Momentum Builds

XRP is showing renewed strength after weeks of volatile trading, with market participants increasingly optimistic that the cryptocurrency could extend its gains before the end of July. Despite consolidating around the $1.13-$1.14 range, traders on prediction platform Kalshi believe XRP still has room to climb, with 33% forecasting the token could reach $1.30 by month-end.

XRPUSD
Tokenpost | 2 weeks ago

Strategy Sells $216M in Bitcoin for Dividends Under 'BTC Monetization Program'

The Bitcoin treasury giant sold $216 million worth of Bitcoin to cover preferred payouts, as an $8.3 billion quarterly loss piled up.

BTCUSD
Decrypt | 2 weeks ago

Brookfield-backed Csquare targets up to $4.18 billion valuation in US IPO

Data center provider Csquare is targeting a valuation of up to $4.18 billion ​in its U.S. initial public offering, riding a wave ‌of investor enthusiasm for companies expected to benefit from the AI boom.

Brookfield Corporation logo BN
Reuters | 2 weeks ago
Load More
Loading...